A plethora of novel therapies--which one to choose?
JB Cohen - Oncology, 2015 - go.gale.com
While the headliners for the 2015 ASCO Annual Meeting featured mainly immunologic
approaches to cancer treatment, with agents such as nivolumab and ipilimumab, the new …
approaches to cancer treatment, with agents such as nivolumab and ipilimumab, the new …